Dossier
analytics firm
Coverage of analytics firm in the Nexus archive.
- Record Chinese biotech out-licensing meets rising US scrutiny
China's growing influence as a biotechnology innovation hub has raised strategic concerns in the United States, prompting policymakers to reassess responses. A leading analytics firm's report highlights implications for pharmaceutical supply-chain resilience, economic competitiveness, and national security.